FindTrial
Sign In

Application for multi-mode imaging in ischemic ophthalmopathy

Application for multi-mode imaging in ischemic ophthalmopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050428
Enrollment
Unknown
Registered
2021-08-27
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic ophthalmopathy

Interventions

Control group:Systematic ophthalmic examination
Patient group:Systematic ophthalmic examination

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have undergone head and neck CTA. 2. Aged >18 years. 3. Gender is not limited.

Exclusion criteria

Exclusion criteria: 1. Other vitreoretinal diseases. 2. History of intraocular surgery and trauma. 3. Infectious diseases and systemic immune system diseases. 4. The refractive medium is severely turbid.

Design outcomes

Primary

MeasureTime frame
Diameter of ophthalmic artery;Ophthalmic artery morphology;Ophthalmic artery flow velocity;Ophthalmic artery blood flow;—

Countries

China

Contacts

Public ContactWang Jialin

Beijing Friendship Hospital, Capital Medical University

wangjialin@bjmu.edu.cn+86 15116994026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026